{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:36:43Z","timestamp":1780609003913,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.ejogrb.2007.01.012","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T12:46:45Z","timestamp":1172839605000},"page":"196-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["Anti-M\u00fcllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"134","author":[{"given":"Asli","family":"Somunkiran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tevfik","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguz","family":"Yucel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2007.01.012_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib2","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib3","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41\u20137.","DOI":"10.1093\/humrep\/deh098"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib4","doi-asserted-by":"crossref","unstructured":"ACOG practice bulletin: Polycycstic Ovary Syndrome. Int J Gynecol Obstet 2003; 80: 335\u201348.","DOI":"10.1016\/S0020-7292(03)00050-X"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib5","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1472-6483(10)61687-2","article-title":"Influence of oral contraceptive pills on phenotype expression in women with polycystic ovary syndrome","volume":"11","author":"Mulders","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3109\/00016349709024348","article-title":"Ovarian volume in gynecologically healthy women using contraception or using IUD","volume":"76","author":"Christensen","year":"1997","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/humrep\/16.1.36","article-title":"Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome","volume":"16","author":"Falsetti","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib8","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1210\/endo.136.11.7588229","article-title":"Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth","volume":"136","author":"Baarends","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib9","first-page":"3836","article-title":"Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells","volume":"84","author":"Rajpert-De Meyts","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib10","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1210\/endo-114-4-1315","article-title":"Production of anti-Mullerian hormone: another homology between Sertoli and granulosa cells","volume":"114","author":"Vigier","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem-70-1-16","article-title":"An immunoassay to detect human mullerian inhibiting substance in males and females during normal development","volume":"70","author":"Hudson","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0378-3782(93)90204-8","article-title":"Anti-mullerian hormone in early human development","volume":"33","author":"Josso","year":"1993","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib13","first-page":"2696","article-title":"Antimullerian hormone in patients with hypogonadotropic hypogonadism","volume":"84","author":"Young","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib14","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0015-0282(97)81417-3","article-title":"Mullerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis","volume":"67","author":"Fallat","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0015-0282(01)02944-2","article-title":"Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women","volume":"77","author":"Cook","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib16","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","article-title":"Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome","volume":"91","author":"Pigny","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-Mullerian hormone (AMH) serum concentrations in normoovulatory and anovulatory women","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib19","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.fertnstert.2004.06.001","article-title":"Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics","volume":"82","author":"La Marca","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib20","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.fertnstert.2005.10.057","article-title":"Serum anti-mullerian hormone levels in women with secondary amenorrhea","volume":"85","author":"La Marca","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/rep.1.00529","article-title":"Anti-Mullerian hormone: a new marker for ovarian function","volume":"131","author":"Visser","year":"2006","journal-title":"Reproduction"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib22","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-Mullerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib23","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jcu.1870090504","article-title":"Medical implications of ultrasonically detected polycystic ovaries","volume":"9","author":"Swanson","year":"1981","journal-title":"J Clin Ultrasound"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmi005","article-title":"Combined oral contraceptives in the treatment of polycystic ovary syndrome","volume":"11","author":"Vrbikova","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib26","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/humrep\/16.7.1527","article-title":"Ovarian and endometrial function during hormonal contraception","volume":"16","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib27","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/humrep\/deh819","article-title":"Volpe A anti-Mullerian hormone concentrations in maternal serum during pregnancy","volume":"20","author":"La Marca","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib28","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/humrep\/deg043","article-title":"Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib29","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"van Rooij","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2007.01.012_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Mol Hum Reprod"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121150700070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121150700070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:17:27Z","timestamp":1759555047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121150700070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S030121150700070X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2007.01.012","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-M\u00fcllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2007.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}